215 related articles for article (PubMed ID: 30128035)
21. Lactate dehydrogenase A silencing in IDH mutant gliomas.
Chesnelong C; Chaumeil MM; Blough MD; Al-Najjar M; Stechishin OD; Chan JA; Pieper RO; Ronen SM; Weiss S; Luchman HA; Cairncross JG
Neuro Oncol; 2014 May; 16(5):686-95. PubMed ID: 24366912
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
[TBL] [Abstract][Full Text] [Related]
23. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
Mai L; Luo M; Wu JJ; Yang JH; Hong LY
Neoplasma; 2019 Sep; 66(5):776-784. PubMed ID: 31169018
[TBL] [Abstract][Full Text] [Related]
24. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells.
Smolková K; Dvořák A; Zelenka J; Vítek L; Ježek P
Int J Biochem Cell Biol; 2015 Aug; 65():125-33. PubMed ID: 26007236
[TBL] [Abstract][Full Text] [Related]
25. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
[TBL] [Abstract][Full Text] [Related]
26. Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9.
Fu Y; Zheng Y; Li K; Huang R; Zheng S; An N; Liang A
Biotechnol Lett; 2012 Mar; 34(3):441-6. PubMed ID: 22105553
[TBL] [Abstract][Full Text] [Related]
27. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
28. Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.
Yu L; Hales CA
BMC Cancer; 2011 Aug; 11():331. PubMed ID: 21812995
[TBL] [Abstract][Full Text] [Related]
29. Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma.
Miyake K; Baba Y; Ishimoto T; Hiyoshi Y; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Ogata Y; Nagayama M; Silsirivanit A; Kobayashi D; Araki N; Baba H
Med Oncol; 2018 Nov; 36(1):11. PubMed ID: 30506321
[TBL] [Abstract][Full Text] [Related]
30. CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.
Bianco AM; Uno M; Oba-Shinjo SM; Clara CA; de Almeida Galatro TF; Rosemberg S; Teixeira MJ; Nagahashi Marie SK
Pathol Oncol Res; 2015 Apr; 21(2):229-40. PubMed ID: 24970694
[TBL] [Abstract][Full Text] [Related]
31. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
[TBL] [Abstract][Full Text] [Related]
32. Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice.
Kim S; Kim SY; Ku HJ; Jeon YH; Lee HW; Lee J; Kwon TK; Park KM; Park JW
Biochim Biophys Acta; 2014 Feb; 1842(2):135-43. PubMed ID: 24240089
[TBL] [Abstract][Full Text] [Related]
33. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer.
He F; Xiao H; Cai Y; Zhang N
Cell Commun Signal; 2021 May; 19(1):53. PubMed ID: 33980247
[TBL] [Abstract][Full Text] [Related]
34. The mineral dust-induced gene,
Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
[TBL] [Abstract][Full Text] [Related]
35. 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
Jin G; Reitman ZJ; Spasojevic I; Batinic-Haberle I; Yang J; Schmidt-Kittler O; Bigner DD; Yan H
PLoS One; 2011 Feb; 6(2):e16812. PubMed ID: 21326614
[TBL] [Abstract][Full Text] [Related]
36. Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells.
Yeung BHY; Huang J; An SS; Solway J; Mitzner W; Tang WY
Am J Respir Cell Mol Biol; 2020 Jul; 63(1):36-45. PubMed ID: 32150688
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
38. IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
Bergaggio E; Riganti C; Garaffo G; Vitale N; Mereu E; Bandini C; Pellegrino E; Pullano V; Omedè P; Todoerti K; Cascione L; Audrito V; Riccio A; Rossi A; Bertoni F; Deaglio S; Neri A; Palumbo A; Piva R
Blood; 2019 Jan; 133(2):156-167. PubMed ID: 30455381
[TBL] [Abstract][Full Text] [Related]
39. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
[TBL] [Abstract][Full Text] [Related]
40. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells.
Chen J; Yang J; Wei Q; Weng L; Wu F; Shi Y; Cheng X; Cai X; Hu C; Cao P
Cell Commun Signal; 2020 Apr; 18(1):55. PubMed ID: 32245484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
